CCL23 and rheumatoid arthritis: Given that FGF-19 is a master protein involved in the inhibition of intestinal inflammation (66, 67) and CCL23 has been positively correlated with the DAS28 score in RA patients (68), we think that it would worth to investigate more in detail the impact of this SNP on drug response in future studies.